Pediatric COVID-19 and Diabetes: An Investigation into the Intersection of Two Pandemics
Abstract
:1. Introduction
1.1. T1DM
1.2. T2DM
2. Diabetes Mellitus and COVID-19 in Children
2.1. T1DM and COVID-19
2.2. T2DM and COVID-19
3. Discussion
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Cardona-Hernandez, R.; Cherubini, V.; Iafusco, D.; Schiaffini, R.; Luo, X.; Maahs, D.M. Children and youth with diabetes are not at increased risk for hospitalization due to COVID-19. Pediatr. Diabetes 2021, 22, 202–206. [Google Scholar] [CrossRef] [PubMed]
- Filippi, C.M.; von Herrath, M.G. Viral trigger for type 1 diabetes: Pros and cons. Diabetes 2008, 57, 2863–2871. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Graff, K.; Smith, C.; Silveira, L.; Jung, S.; Curran-Hays, S.; Jarjour, J.; Carpenter, L.; Pickard, K.; Mattiucci, M.; Fresia, J.; et al. Risk Factors for Severe COVID-19 in Children. Pediatr. Infect. Dis. J. 2021, 40, e137–e145. [Google Scholar] [CrossRef] [PubMed]
- Nielsen-Saines, K.; Li, E.; Olivera, A.M.; Martin-Blais, R.; Bulut, Y. Case Report: Insulin-Dependent Diabetes Mellitus and Diabetic Keto-Acidosis in a Child with COVID-19. Front. Pediatr. 2021, 9, 628810. [Google Scholar] [CrossRef] [PubMed]
- CDC COVID-19 Response Team. Coronavirus Disease 2019 in Children-United States, February 12–April 2, 2020. MMWR Morb. Mortal. Wkly. Rep. 2020, 69, 422–426. [Google Scholar] [CrossRef]
- Weisberg, S.P.; Connors, T.J.; Zhu, Y.; Baldwin, M.R.; Lin, W.H.; Wontakal, S.; Szabo, P.A.; Wells, S.B.; Dogra, P.; Gray, J.; et al. Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum. Nat. Immunol. 2021, 22, 25–31. [Google Scholar] [CrossRef]
- Vogel, T.P.; Top, K.A.; Karatzios, C.; Hilmers, D.C.; Tapia, L.I.; Moceri, P.; Giovannini-Chami, L.; Wood, N.; Chandler, R.E.; Klein, N.P.; et al. Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine 2021, 39, 3037–3049. [Google Scholar]
- Matic, K.M. SARS-CoV-2 and Multisystem Inflammatory Syndrome in Children (MIS-C). Curr. Probl. Pediatr. Adolesc. Health Care 2021, 51, 101000. [Google Scholar] [CrossRef]
- Mihai, C.M.; Chisnoiu, T.; Cambrea, C.S.; Frecus, C.E.; Mihai, L.; Balasa, A.L.; Stroe, A.Z.; Gogu, A.E.; Docu Axelerad, A. Neurological manifestations found in children with multisystem inflammatory syndrome. Exp. Ther. Med. 2022, 23, 261. [Google Scholar] [CrossRef]
- Lu, X.; Zhang, L.; Du, H.; Zhang, J.; Li, Y.Y.; Qu, J.; Zhang, W.; Wang, Y.; Bao, S.; Li, Y.; et al. SARS-CoV-2 Infection in Children. N. Engl. J. Med. 2020, 382, 1663–1665. [Google Scholar] [CrossRef] [Green Version]
- American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care 2018, 41 (Suppl. 1), S13–S27. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Roep, B.O.; Thomaidou, S.; van Tienhoven, R.; Zaldumbide, A. Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?). Nat. Rev. Endocrinol. 2021, 17, 150–161. [Google Scholar] [CrossRef]
- Crawford, J.M. Liver, biliary tract, and pancreas. In Pocket Companion to Robbins Pathologic Basis of Disease; Robbins, S.L., Cotran, R.S., Kumar, V., Eds.; WB Saunders: Philadelphia, PA, USA, 1991; pp. 313–317. [Google Scholar]
- Ziegler, R.; Neu, A. Diabetes in Childhood and Adolescence. Dtsch. Arztebl. Int. 2018, 115, 146–156. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wolfsdorf, J.I.; Allgrove, J.; Craig, M.E.; Edge, J.; Glaser, N.; Jain, V.; Lee, W.W.; Mungai, L.N.; Rosenbloom, A.L.; Sperling, M.A.; et al. ISPAD Clinical Practice Consensus Guidelines 2014. Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr. Diabetes 2014, 15, 154–179. [Google Scholar] [CrossRef] [PubMed]
- Couper, J.J.; Haller, M.J.; Greenbaum, C.J.; Ziegler, A.G.; Wherrett, D.K.; Knip, M.; Craig, M.E. ISPAD Clinical Practice Consensus Guidelines 2018: Stages of type 1 diabetes in children and adolescents. Pediatr. Diabetes 2018, 19 (Suppl. 27), 20–27. [Google Scholar] [CrossRef] [PubMed]
- Couch, R.; Jetha, M.; Dryden, D.M.; Hooton, N.; Liang, Y.; Durec, T.; Sumamo, E.; Spooner, C.; Milne, A.; O’Gorman, K.; et al. Diabetes Education for Children with Type 1 Diabetes Mellitus and Their Families; (Evidence Reports/Technology Assessments, No. 166.) 1, Introduction; Agency for Healthcare Research and Quality (US): Rockville, MD, USA, 2008.
- UK Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and 2 diabetes: Effects of treatment modalities and their duration. Diabetologia 2007, 50, 1140–1147. [Google Scholar] [CrossRef] [Green Version]
- Rundle, A.G.; Park, Y.; Herbstman, J.B.; Kinsey, E.W.; Wang, Y.C. COVID-19 related school closings and risk of weight gain among children. Obesity 2020, 28, 1008. [Google Scholar] [CrossRef]
- Urakami, T. Severe Hypoglycemia: Is It Still a Threat for Children and Adolescents with Type 1 Diabetes? Front. Endocrinol. 2020, 11, 609. [Google Scholar] [CrossRef]
- Mine, K.; Nagafuchi, S.; Mori, H.; Takahashi, H.; Anzai, K. SARS-CoV-2 Infection and Pancreatic β Cell Failure. Biology 2022, 11, 22. [Google Scholar] [CrossRef]
- Vlad, A.; Serban, V.; Timar, R.; Sima, A.; Botea, V.; Albai, O.; Timar, B.; Vlad, M. Increased Incidence of Type 1 Diabetes during the COVID-19 Pandemic in Romanian Children. Medicina 2021, 57, 973. [Google Scholar] [CrossRef]
- Hollstein, T.; Schulte, D.M.; Schulz, J.; Glück, A.; Ziegler, A.G.; Bonifacio, E.; Wendorff, M.; Franke, A.; Schreiber, S.; Bornstein, S.R.; et al. Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: A case report. Nat. Metab. 2020, 2, 1021–1024. [Google Scholar] [CrossRef] [PubMed]
- Galicia-Garcia, U.; Benito-Vicente, A.; Jebari, S.; Larrea-Sebal, A.; Siddiqi, H.; Uribe, K.B.; Ostolaza, H.; Martín, C. Pathophysiology of Type 2 Diabetes Mellitus. Int. J. Mol. Sci. 2020, 21, 6275. [Google Scholar] [CrossRef] [PubMed]
- Reinehr, T. Type 2 diabetes mellitus in children and adolescents. World J. Diabetes 2013, 4, 270–281. [Google Scholar] [CrossRef]
- Mayer-Davis, E.J.; Kahkoska, A.R.; Jefferies, C.; Dabelea, D.; Balde, N.; Gong, C.X.; Aschner, P.; Craig, M.E. ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr. Diabetes 2018, 19 (Suppl. 27), 7–19. [Google Scholar] [CrossRef] [PubMed]
- Pham, T.M.; Carpenter, J.R.; Morris, T.P.; Sharma, M.; Petersen, I. Ethnic Differences in the Prevalence of Type 2 Diabetes Diagnoses in the UK: Cross-Sectional Analysis of the Health Improvement Network Primary Care Database. Clin. Epidemiol. 2019, 11, 1081–1088. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tamborlane, W.V.; Haymond, M.W.; Dunger, D.; Shankar, R.; Gubitosi-Klug, R.; Bethin, K.; Karres, J.; Tomasi, P.; Libman, I.; Hale, P.H.; et al. Expanding treatment options for youth with type 2 diabetes: Current problems and proposed solutions: A white paper from the NICHD diabetes working group. Diabetes Care 2016, 393, 323–329. [Google Scholar] [CrossRef] [Green Version]
- Hutchins, J.; Barajas, R.A.; Hale, D.; Escaname, E.; Lynch, J. Type 2 diabetes in a 5-year-old and single center experience of type 2 diabetes in youth under 10. Pediatr. Diabetes 2017, 18, 674–677. [Google Scholar] [CrossRef]
- Nambam, B.; Silverstein, J.; Cheng, P.; Ruedy, K.J.; Beck, R.W.; Paul Wadwa, R.; Klingensmith, G.; Willi, S.M.; Wood, J.R.; Bacha, F.; et al. A cross-sectional view of the current state of treatment of youth with type 2 diabetes in the USA: Enrollment data from the Pediatric Diabetes Consortium Type 2 Diabetes Registry: PDC Type 2 Diabetes Registry. Pediatr. Diabetes 2017, 18, 222–229. [Google Scholar] [CrossRef]
- Scaramuzza, A.E.; Rabbone, I.; Maffeis, C.; Schiaffini, R.; Diabetes Study Group of the Italian Society for Pediatric Endocrinology, Diabetes. Seasonal flu and COVID-19 recommendations for children, adolescents and young adults with diabetes. Diabet. Med. 2021, 38, e14427. [Google Scholar] [CrossRef]
- Güemes, M.; Storch-de-Gracia, P.; Enriquez, S.V.; Martín-Rivada, Á.; Brabin, A.G.; Argente, J. Severity in pediatric type 1 diabetes mellitus debut during the COVID-19 pandemic. J. Pediatr. Endocrinol. Metab. 2020, 33, 1601–1603. [Google Scholar] [CrossRef]
- Kamrath, C.; Mönkemöller, K.; Biester, T.; Rohrer, T.R.; Warncke, K.; Hammersen, J.; Holl, R.W. Ketoacidosis in Children and Adolescents with Newly Diagnosed Type 1 Diabetes During the COVID-19 Pandemic in Germany. JAMA 2020, 324, 801–804. [Google Scholar] [CrossRef] [PubMed]
- Unsworth, R.; Wallace, S.; Oliver, N.S.; Yeung, S.; Kshirsagar, A.; Naidu, H.; Kwong, R.M.W.; Kumar, P.; Logan, K.M. New-onset type 1 diabetes in children during COVID-19: Multicenter regional findings in the U.K. Diabetes Care 2020, 43, e170–e171. [Google Scholar] [CrossRef] [PubMed]
- Tang, X.; Uhl, S.; Zhang, T.; Xue, D.; Li, B.; Vandana, J.J.; Acklin, J.A.; Bonnycastle, L.L.; Narisu, N.; Erdos, M.R.; et al. SARS-CoV-2 infection induces beta cell transdifferentiation. Cell Metab. 2021, 33, 1577–1591.e7. [Google Scholar] [CrossRef] [PubMed]
- Hamming, I.; Timens, W.; Bulthuis, M.L.; Lely, A.T.; Navis, G.V.; van Goor, H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. A J. Pathol. Soc. Great Br. Irel. 2004, 203, 631–637. [Google Scholar] [CrossRef]
- Wu, C.T.; Lidsky, P.V.; ** diabetes 5 months postacute SARS-CoV-2 infection: A retrospective cohort study. BMJ Open Diabetes Res. Care 2023, 11, e003257. [Google Scholar] [CrossRef] [PubMed]
- Wander, P.L.; Lowy, E.; Beste, L.A.; Tulloch-Palomino, L.; Korpak, A.; Peterson, A.C.; Kahn, S.E.; Boyko, E.J. The Incidence of Diabetes Among 2,777,768 Veterans with and without Recent SARS-CoV-2 Infection. Diabetes Care 2022, 45, 782–788, Erratum in Diabetes Care 2023. [Google Scholar] [CrossRef] [PubMed]
- Ilic, I.; Ilic, M. Diabetes Mellitus after SARS-CoV-2 Infection: An Epidemiological Review. Life 2023, 13, 1233. [Google Scholar] [CrossRef]
- Ng, S.M. COVID-19 and children with diabetes: Emerging knowledge. Pract. Diabetes 2020, 37, 147–148a. [Google Scholar] [CrossRef]
- Wu, Z.; McGoogan, J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. JAMA 2020, 323, 1239–1242. [Google Scholar] [CrossRef]
- Pal, R.; Bhadada, S.K.; Misra, A. COVID-19 vaccination in patients with diabetes mellitus: Current concepts, uncertainties and challenges. Diabetes Metab. Syndr. 2021, 15, 505–508. [Google Scholar] [CrossRef]
- Gregory, J.M.; Slaughter, J.C.; Duffus, S.H.; Smith, T.J.; LeStourgeon, L.M.; Jaser, S.S.; McCoy, A.B.; Luther, J.M.; Giovannetti, E.R.; Boeder, S.; et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic’s Im-pact in Type 1 and Type 2 Diabetes. Diabetes Care 2021, 44, 526–532. [Google Scholar] [CrossRef]
- Mohseni Afshar, Z.; Babazadeh, A.; Janbakhsh, A.; Mansouri, F.; Sio, T.T.; Sullman, M.J.M.; Carson-Chahhoud, K.; Hosseinzadeh, R.; Barary, M.; Ebrahimpour, S. Coronavirus disease 2019 (COVID-19) vaccination recommendations in special populations and pa-tients with existing comorbidities. Rev. Med. Virol. 2022, 32, e2309. [Google Scholar]
- Muñoz, C.E.; Chao, L.C. Impact of COVID-19 on Youth with Type 2 Diabetes: Lessons Learned from a Pediatric Endocrinologist and a Psychologist. Front. Endocrinol. 2021, 12, 650492. [Google Scholar] [CrossRef] [PubMed]
Author | Year | Regions | Age (Years) | Study Period | Findings |
---|---|---|---|---|---|
Rabbone et al. [46] | 2020 | Italy | NA | 2019–2020 | Decrease in diabetes presentation and in severity of DKA |
Dayal et al. [47] | 2020 | India | Pediatric population | April 2019–March 2020 | Major reduction in hospitalization of children with onset of T1DM in April 2020 |
Brothers et al. [42] | 2021 | NA | 12 | NA | Sepsis due to Candida glabrata in a teenager with COVID-19 and T1DM |
Williams et al. [48] | 2021 | United Kingdom | Pediatric population | 1 January–31 July 2020 | No evidence of diagnostic delay or increased illness severity for childhood cancer or T1DM |
Ng et al. [108] | 2020 | United Kingdom | Pediatric population | 1 March 2020–30 June 2020 | An increased percentage of DKA was observed during the pandemic |
Mianowska et al. [96] | 2021 | Poland | T1DM aged 8–18 years and their parents | November 2019–February 2020 | COVID-19 lockdown did not seem to aggravate diabetes manifestations |
Rahmati et al. [101] | 2022 | NA | T1DM pediatric patients | Up to March 2022 | Notable increase in the worldwide incidence of pediatric new-onset T1DM, DKA, and severe DKA during the initial year of the pandemic |
Lee et al. [81] | 2022 | South Korea | T1DM or T2DM patients <18 years | 2018–2020 | During the pandemic, the proportion of DKA cases increased compared to the pre-pandemic period |
Wu et al. [109] | 2021 | China | T1DM pediatric patients | 1 November 2019–31 July 2020 | Glycemic control did not decrease in T1DM pediatric patients during the COVID-19 pandemic |
Sadisharan Pillai et al. [77] | 2023 | United States | New-onset T2DM pediatric patients | 1 January 2017–31 December 2021 | The yearly occurrence of T2DM demonstrated an almost threefold rise during the pandemic compared to the preceding period |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Fotea, S.; Ghiciuc, C.M.; Stefanescu, G.; Cianga, A.L.; Mihai, C.M.; Lupu, A.; Butnariu, L.I.; Starcea, I.M.; Salaru, D.L.; Mocanu, A.; et al. Pediatric COVID-19 and Diabetes: An Investigation into the Intersection of Two Pandemics. Diagnostics 2023, 13, 2436. https://doi.org/10.3390/diagnostics13142436
Fotea S, Ghiciuc CM, Stefanescu G, Cianga AL, Mihai CM, Lupu A, Butnariu LI, Starcea IM, Salaru DL, Mocanu A, et al. Pediatric COVID-19 and Diabetes: An Investigation into the Intersection of Two Pandemics. Diagnostics. 2023; 13(14):2436. https://doi.org/10.3390/diagnostics13142436
Chicago/Turabian StyleFotea, Silvia, Cristina Mihaela Ghiciuc, Gabriela Stefanescu, Anca Lavinia Cianga, Cristina Maria Mihai, Ancuta Lupu, Lacramioara Ionela Butnariu, Iuliana Magdalena Starcea, Delia Lidia Salaru, Adriana Mocanu, and et al. 2023. "Pediatric COVID-19 and Diabetes: An Investigation into the Intersection of Two Pandemics" Diagnostics 13, no. 14: 2436. https://doi.org/10.3390/diagnostics13142436